Main Content

Press Release


ELEKTA INVESTOR EVENTS – SAVE THE DATES!

Stockholm, February 3, 2006

During the spring of 2006, Elekta will issue its quarterly financial reports and arrange investor events as listed below. Separate invitations for the teleconference and capital market days will be sent out approx. three weeks in advance.

NOTE: If not otherwise stated, all times listed are in Swedish time (GMT+1), which is 1 hour ahead of UK time and 6 hours ahead of US Eastern time.

• March 8, at around 13.00 (1pm): Publication of Elekta’s 9 months results.

• March 8, at 15.00 (3pm): Teleconference following the 9 months results.

• March 15, at 10am – 1pm US Eastern Time: Capital markets day with Tomas Puusepp, President and CEO of Elekta. Location: Scandinavia House at 58 Park Avenue, New York.

• June 14, at around 13.00 (1pm): Publication of Elekta’s full year results for fiscal year 2005/06.

• June 15, 14.00 – 17.00 (2-5pm): Capital markets day at Elekta’s corporate head office. Location: Kungstensgatan 18 in central Stockholm, Sweden.


Call-in details for the teleconference on March 8:

Sweden: +46 (0) 85 052 0114
U.K. (Europe): +44 (0) 20 7162 0125
U.S: +1 334 323 6203
Password: Elekta

(Please note: for Local Connect dial-in numbers – you must always dial the area code to enter the conference.)

Webcasts

The March 8 teleconference and the June 15 CMD will also be broadcasted over the Internet (audio only). Please go http://www.elekta.com/investors and follow the link.


For further information, please contact:

United States: Lars Jonsteg, VP Investor Relations North America, Elekta, USA
Phone: +46 708 78 37 35, e-mail: lars.jonsteg@elekta.com

International: Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

******
About Elekta

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.

Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world’s largest supplier of oncology software.

Elekta’s systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.

With approx. 1700 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.


This information was brought to you by Waymaker http://www.waymaker.net